CSIMarket


Applied Uv Inc   (AUVI)
Other Ticker:  
 

Applied Uv Inc

AUVI's Fundamental analysis








Looking into Applied Uv Inc growth rates, revenue grew by 65.44 % in III. Quarter 2022 from the same quarter a year ago. Ranking at No. 472

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -3.91 %



More on AUVI's Growth


Applied Uv Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Applied Uv Inc PEG ratio is at -0.03
Company
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.56.


More on AUVI's Valuation
 
 Total Debt (Millions $) 0
 Dividend TTM ($) 0.03 $
 Dividend Yield TTM (%) 3.53 %
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 7.55
 Tangible Book Value (Per Share $)

Applied Uv Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Applied Uv Inc PEG ratio is at -0.03
Company
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.56.